Your browser doesn't support javascript.
loading
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations.
Jung, Seungyeon; Armstrong, Emma; Wei, Alexander Z; Ye, Fei; Lee, Aaron; Carlino, Matteo S; Sullivan, Ryan J; Carvajal, Richard D; Shoushtari, Alexander N; Johnson, Douglas B.
Afiliação
  • Jung S; Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Armstrong E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wei AZ; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Ye F; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Lee A; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Carlino MS; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Sullivan RJ; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Carvajal RD; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Shoushtari AN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Johnson DB; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA. douglas.b.johnson@vumc.org.
Br J Cancer ; 127(9): 1726-1732, 2022 11.
Article em En | MEDLINE | ID: mdl-35999272
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article